<DOC>
	<DOCNO>NCT02062125</DOCNO>
	<brief_summary>This 10 year study scleroderma patient calcinosis 1 ) good understand common risk factor calcinosis 2 ) identify common complication associate scleroderma-related calcinosis .</brief_summary>
	<brief_title>Calcinosis Single-Center Scleroderma Population</brief_title>
	<detailed_description>This prospective study scleroderma- spectrum patient focus soft tissue calcinosis order 1 ) good understand risk factor ( include clinical/laboratory characteristic , serology ) calcinosis scleroderma-spectrum disorder ( limited diffuse systemic sclerosis without overlap inflammatory arthritis and/or myositis ) . 2 ) view common complication associate calcinosis . Better understanding scleroderma calcinosis would lead study eventually define good treatment option incurable often disable complication .</detailed_description>
	<mesh_term>Scleroderma , Systemic</mesh_term>
	<mesh_term>Scleroderma , Diffuse</mesh_term>
	<mesh_term>Scleroderma , Localized</mesh_term>
	<mesh_term>Calcinosis</mesh_term>
	<criteria>Adult scleroderma subject without calcinosis Subjects unwilling participate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>scleroderma</keyword>
	<keyword>calcinosis</keyword>
</DOC>